These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28338545)

  • 1. Risperidone and Cardiometabolic Risk in Children and Adolescents: Clinical and Instrumental Issues.
    Matera E; Margari L; Palmieri VO; Zagaria G; Palumbi R; Margari F
    J Clin Psychopharmacol; 2017 Jun; 37(3):302-309. PubMed ID: 28338545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability and safety profile of risperidone in a sample of children and adolescents.
    Margari L; Matera E; Craig F; Petruzzelli MG; Palmieri VO; Pastore A; Margari F
    Int Clin Psychopharmacol; 2013 Jul; 28(4):177-83. PubMed ID: 23689836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naïve patients.
    Arango C; Giráldez M; Merchán-Naranjo J; Baeza I; Castro-Fornieles J; Alda JA; Martínez-Cantarero C; Moreno C; de Andrés P; Cuerda C; de la Serna E; Correll CU; Fraguas D; Parellada M
    J Am Acad Child Adolesc Psychiatry; 2014 Nov; 53(11):1179-90,1190.e1-4. PubMed ID: 25440308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiometabolic outcomes in children and adolescents following discontinuation of long-term risperidone treatment.
    Calarge CA; Nicol G; Schlechte JA; Burns TL
    J Child Adolesc Psychopharmacol; 2014 Apr; 24(3):120-9. PubMed ID: 24725198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.
    Moreno C; Merchán-Naranjo J; Alvarez M; Baeza I; Alda JA; Martínez-Cantarero C; Parellada M; Sánchez B; de la Serna E; Giráldez M; Arango C
    Bipolar Disord; 2010 Mar; 12(2):172-84. PubMed ID: 20402710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological Adverse Effects of Antipsychotics in Children and Adolescents.
    Garcia-Amador M; Merchán-Naranjo J; Tapia C; Moreno C; Castro-Fornieles J; Baeza I; de la Serna E; Alda JA; Muñoz D; Andrés Nestares P; Cantarero CM; Arango C
    J Clin Psychopharmacol; 2015 Dec; 35(6):686-93. PubMed ID: 26505569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Metabolic Syndrome in Drug-Naive Adolescents After 12 Months of Second-Generation Antipsychotic Treatment.
    Sjo CP; Stenstrøm AD; Bojesen AB; Frølich JS; Bilenberg N
    J Child Adolesc Psychopharmacol; 2017 Dec; 27(10):884-891. PubMed ID: 28783382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient, Treatment, and Health Care Utilization Variables Associated with Adherence to Metabolic Monitoring Practices in Children and Adolescents Taking Second-Generation Antipsychotics.
    Coughlin M; Goldie CL; Tranmer J; Khalid-Khan S; Tregunno D
    Can J Psychiatry; 2018 Apr; 63(4):240-249. PubMed ID: 29528720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and metabolic monitoring of children and adolescents on antipsychotic treatment: A cross-sectional descriptive study.
    de la Torre Villalobos M; Martin-López LM; Fernández Sanmartín MI; Pujals Altes E; Gasque Llopis S; Batlle Vila S; Pérez-Solá V; Novo Navarro P; Gómez Simón I; Fresno González C; Camprodon Rosanas E; Bulbena Vilarrasa A
    Rev Psiquiatr Salud Ment (Engl Ed); 2018; 11(1):19-26. PubMed ID: 27291832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study.
    Patel JK; Buckley PF; Woolson S; Hamer RM; McEvoy JP; Perkins DO; Lieberman JA;
    Schizophr Res; 2009 Jun; 111(1-3):9-16. PubMed ID: 19398192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative cardiometabolic risk of antipsychotics in children, adolescents and young adults.
    Chung YS; Shao SC; Chi MH; Lin SJ; Su CC; Kao Yang YH; Yang YK; Lai EC
    Eur Child Adolesc Psychiatry; 2021 May; 30(5):769-783. PubMed ID: 32472205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of pubertal stage and body mass index with cardiometabolic risk in Hong Kong Chinese children: A cross-sectional study.
    Chan NP; Choi KC; Nelson EA; Chan JC; Kong AP
    BMC Pediatr; 2015 Sep; 15():136. PubMed ID: 26403455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and Relevance of Antipsychotic Safety Monitoring in Children With Tourette Syndrome: A Prospective Longitudinal Study.
    Pringsheim T; Ho J; Sarna JR; Hammer T; Patten S
    J Clin Psychopharmacol; 2017 Oct; 37(5):498-504. PubMed ID: 28816926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone-associated weight gain in children and adolescents: a retrospective chart review.
    Martin A; Landau J; Leebens P; Ulizio K; Cicchetti D; Scahill L; Leckman JF
    J Child Adolesc Psychopharmacol; 2000; 10(4):259-68. PubMed ID: 11191686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of resting energy expenditure on weight gain in adolescents taking second-generation antipsychotics.
    Cuerda C; Merchan-Naranjo J; Velasco C; Gutierrez A; Leiva M; de Castro MJ; Parellada M; Giráldez M; Bretón I; Camblor M; García-Peris P; Dulín E; Sanz I; Desco M; Arango C
    Clin Nutr; 2011 Oct; 30(5):616-23. PubMed ID: 21492975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of olanzapine and risperidone on metabolic factors in children and adolescents: a retrospective evaluation.
    Khan RA; Mican LM; Suehs BT
    J Psychiatr Pract; 2009 Jul; 15(4):320-8. PubMed ID: 19625888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of weight gain and cardiometabolic abnormalities in children and adolescents.
    Calarge CA; Xie D; Fiedorowicz JG; Burns TL; Haynes WG
    J Pediatr; 2012 Dec; 161(6):1010-5. PubMed ID: 22738944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.